Cargando…
Autoimmune disorders but not heparin are associated with cell-free fetal DNA test failure
BACKGROUND: Recent studies have suggested a possible association between heparin treatment at the time of cell-free DNA (cfDNA) testing and a non-reportable result. However, these studies lack of proper methodology and had a low level of proof to firmly incriminate heparin. Our objective was to inve...
Autores principales: | Dabi, Yohann, Guterman, Sarah, Jani, Jacques C., Letourneau, Alexandra, Demain, Adèle, Kleinfinger, Pascale, Lohmann, Laurence, Costa, Jean-Marc, Benachi, Alexandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276207/ https://www.ncbi.nlm.nih.gov/pubmed/30509296 http://dx.doi.org/10.1186/s12967-018-1705-2 |
Ejemplares similares
-
Usefulness and reliability of cell free fetal DNA screening for main trisomies in case of atypical profile on first trimester maternal serum screening
por: Carrara, Julie, et al.
Publicado: (2019) -
Clinical validation of a model predicting the risk of preterm delivery
por: Dabi, Yohann, et al.
Publicado: (2017) -
Case Report: How whole-genome sequencing-based cell-free DNA prenatal testing can help identify a marker mhromosome
por: Kleinfinger, Pascale, et al.
Publicado: (2022) -
Failure of Fondaparinux in Autoimmune Heparin-Induced Thrombocytopenia
por: Sartori, Michelangelo, et al.
Publicado: (2020) -
Strategy for Use of Genome-Wide Non-Invasive Prenatal Testing for Rare Autosomal Aneuploidies and Unbalanced Structural Chromosomal Anomalies
por: Kleinfinger, Pascale, et al.
Publicado: (2020)